上海
分享至
8月2日上午，港股宜明昂科-B逆市涨超11%，公司就两款癌症创新药达成授权合作，总金额超20亿美元。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
